Insception Biosciences
Insception Biosciences (Insception Lifebank) is Canada's oldest and largest family cord blood and tissue bank, founded 1996, serving expectant parents with cryopreservation services for newborn stem cells at hospital partners and home births, and operating as a subsidiary of CooperSurgical.
- Company typePrivate
- Founded1996
- HeadquartersMississauga, Canada
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Insception Biosciences does
Insception Biosciences (operating as Insception Lifebank) is a Canadian family cord blood and cord tissue banking company headquartered in Mississauga, Ontario, founded in 1996 by Canadian stem cell researchers Dr. Robert Casper, Dr. Ian Rogers, and Dr. Peter Zandstra. The company collects, processes, and cryopreserves umbilical cord blood (hematopoietic stem cells) and cord tissue (mesenchymal stem cells) for family use, with processing and long-term storage performed at CooperSurgical's 80,000-square-foot facility in Tucson, Arizona at temperatures below -150°C. It operates as a subsidiary of CooperSurgical, the women's healthcare group that owns the world's largest family newborn stem cell preservation network with more than 1.2 million samples stored globally; Insception itself holds more than 109,752 Canadian units, representing over 80% of total Canadian family cord blood banking volume. The business model is direct-to-consumer with a B2B2C hospital channel: revenue is generated from one-time initial processing fees ($1,125-$2,995 depending on product and birth configuration) plus recurring annual storage fees ($180-$690) and prepaid 18-year or lifetime plans reaching $8,190 for combined cord blood and tissue. Distribution combines formal on-site hospital partnerships at Mount Sinai, Sunnybrook, Humber River Health, and Royal Victoria Regional Health Centre — where clinical consultants perform bedside education and pickup — with online enrollment, parent education sessions, and a referral program. Insception is accredited by AABB, the FDA, Health Canada (CTO Regulations), and ISO 9001:2015, and is a founding member of the Cord Blood Association. Public funding history is limited to a $2.75M round from MMV Capital Partners (2006) and a $4.5M round from Wellington Financial (2012); revenue is not publicly disclosed and the company is privately held.
Insception Biosciences firmographics
Firmographics- Name
- Insception Biosciences
- Legal name
- Insception Bioscience Inc.
- Website
- https://insception.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Insception Biosciences (Insception Lifebank) is Canada's oldest and largest family cord blood and tissue bank, founded 1996, serving expectant parents with cryopreservation services for newborn stem cells at hospital partners and home births, and operating as a subsidiary of CooperSurgical.
- Ownership category
- akta.pro rank
Insception Biosciences industry classification
Industry- Product category
- Cord Blood and Tissue Banking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
Keywords
Where Insception Biosciences is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Offices5 records
Markets served
Insception Biosciences business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Cord Blood Banking Services: One-time initial fees for collection kit, processing, and testing of cord blood, combined with recurring annual storage fees. Payment plans allow spreading initial fees over 12 months. Prepaid plans for 18 years or lifetime storage are available.
- Cord Tissue Banking Services: Separate banking service for cord tissue (MSCs) with its own initial processing fee and annual storage charges. Often bundled with cord blood banking.
- Prepaid Storage Plans: 18-year or lifetime prepaid storage plans combining initial fees with storage fees upfront, offering cost savings compared to annual payments.
- Referral Program Revenue: Referral program incentivizes existing clients to refer new customers, with both referrer and referee receiving discounts/credits upon successful storage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Cord Blood Only - Annual Payment |
| One time/ perpetual license | Multi-year contract | Cord Blood Only - 18 Years Prepaid |
| One time/ perpetual license | Multi-year contract | Cord Blood Only - Lifetime Prepaid |
| Subscription | Annual | Cord Blood & Tissue - Annual Payment |
| One time/ perpetual license | Multi-year contract | Cord Blood & Tissue - 18 Years Prepaid |
| One time/ perpetual license | Multi-year contract | Cord Blood & Tissue - Lifetime Prepaid |
| Subscription | Annual | Twins - Cord Blood Only - Annual Payment |
| Subscription | Annual | Twins - Cord Blood & Tissue - Annual Payment |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels8 records
Insception Biosciences product offering
Product offeringCore offering
Insception Lifebank provides family cord blood and cord tissue banking services, collecting, processing, and cryogenically storing newborn stem cells at CooperSurgical's 80,000-square-foot facility in Tucson, Arizona. Cord blood (hematopoietic stem cells) and cord tissue (mesenchymal stem cells) are preserved for potential future use in treating 80+ diseases. The company also offers the Newborn Possibilities Program providing free processing and storage to families with qualifying medical needs.
Product overview
Insception Lifebank is a family cord blood and tissue banking service offering two core products: Cord Blood Banking and Cord Tissue Banking. Cord blood, rich in hematopoietic stem cells, can be used for bone marrow transplants treating 80+ diseases. Cord tissue provides mesenchymal stem cells with regenerative medicine potential. The company also offers the Newborn Possibilities Program for families with qualifying medical needs, providing free processing and five years of storage. Additional services include collection kits, laboratory processing at CooperSurgical's Arizona facility, and parent education sessions. Founded in 1996, it is Canada's largest and most experienced cord blood program, storing over 109,752 cord blood units and operating as part of the CooperSurgical family of cord blood banks.
Differentiator
Problem solved
Functional benefit
Products and services
- Cord Blood Banking Primary service for collecting, processing, and long-term cryogenic storage of umbilical cord blood stem cells for family use. Cord blood contains hematopoietic (blood-forming) stem cells used in bone marrow transplants for 80+ diseases including cancers, genetic diseases, and blood disorders. Available at all Canadian hospitals and home births.
- Cord Tissue Banking Service for collecting and storing a segment of the umbilical cord, which is a rich source of mesenchymal stem cells (MSCs). Cord tissue MSCs have potential for regenerative medicine applications including tissue repair, bone and cartilage differentiation, and immune response suppression. Often bundled with Cord Blood Banking.
- Newborn Possibilities Program No-cost preservation program offering cord blood and tissue processing plus five years of storage for families with a qualifying medical need, including babies with sick siblings/parents or identified health conditions prenatally or at birth.
Quantifiable outcome
- 80+ diseases treatable with cord blood stem cells
- +3 more outcomes
Companies that use Insception Biosciences
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles3 records
Insception Biosciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Insception Biosciences partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Humber River HealthcorePartnership established in 2019. Humber River Hospital welcomes more than 4,500 births annually with a 16-bed NICU. Clinical consultant available at education kiosk in Prenatal Triage Department. Preferred independent vendor for cord blood banking education.
- Sunnybrook Health Sciences CentrecorePartnership started September 2013 to advance education and services regarding cord blood banking. Sunnybrook is home to one of Canada's largest high-risk birthing centres and neonatal intensive care units. On-site clinical consultant provides education, materials, and support.
- Mount Sinai HospitalcorePartnership since 2004 to enhance quality of stem cell collection and storage for Mount Sinai patients. Satellite office located within Ontario Power Generation Building at 700 University Ave, Room 3-103, Toronto. On-site clinical consultant available to answer questions about cord blood and cord tissue banking.
- Royal Victoria Regional Health CentrecorePartnership with leading medical institution for stem cell collection and education services.
- Centre for Commercialization of Regenerative Medicine (CCRM)minorInsception Lifebank sponsors CCRM, a Canadian not-for-profit public-private consortium funded by Government of Canada's Networks of Centres of Excellence. CCRM supports development of technologies that accelerate commercialization of stem cell and biomaterials-based therapies.
- CooperSurgicalcoreInsception is a subsidiary of CooperSurgical, a renowned name in women's healthcare. Together they form the world's largest newborn stem cell family preservation bank with 1.2 million samples stored worldwide. CooperSurgical operates the 80,000 sq ft processing facility in Tucson, Arizona.
- University of Toronto - Lunenfeld-Tanenbaum Research InstitutecoreDr. Robert Casper (Founder & Medical Director) and Dr. Ian Rogers (Founder & Scientific Director) are associated with this research institute. Research focuses on in vitro expansion of cord blood stem cells and regenerative capacity of adult stem cells.
- Duke University School of MedicineminorDuke University conducts clinical trials using cord blood for conditions including autism, cerebral palsy, hypoplastic left heart syndrome, stroke, and metabolic disorders. Insception families participate in Duke's Expanded Access Protocol.
Scale indicators11 records
Recent moves6 records
Insception Biosciences competitors and assessment
Company assessmentDirect peers
- Cells for Life: Canadian family cord blood and cord tissue bank operating as a direct competitor to Insception in the same Canadian consumer market with comparable hospital-partner distribution and pricing tiers.
- Healthcord Cryogenics: Canadian cord blood bank competing head-to-head with Insception on direct-to-consumer family banking, with overlapping hospital partnerships and similar cryopreservation offerings.
- ViaCord: US-based family cord blood and cord tissue bank (owned by Revvity/PerkinElmer) offering the same core hematopoietic stem cell banking service with comparable storage tiers and consumer marketing approach.
- Cord Blood Registry (CBR): Sister brand under CooperSurgical's family of cord blood banks; the largest US family cord blood bank and a sibling within the same parent organization that shares processing infrastructure with Insception.
- Cryo-Cell International: Publicly traded US cord blood bank offering comparable family banking services, premium processing tiers, and menstrual stem cell banking — a publicly visible benchmark for the cord blood banking business model.
- StemCyte: Hybrid public/private cord blood bank operating in the US and internationally with comparable cryopreservation services and an overlapping customer base of expectant parents.
- LifebankUSA: Family cord blood and placenta blood bank offering similar cryogenic storage services with comparable pricing structure and consumer-direct enrollment model.
- AlphaCord: US-based family cord blood and tissue bank offering comparable storage services, AABB accreditation, and direct-to-consumer enrollment targeting expectant parents.
- FamilyCord: Family cord blood and cord tissue bank offering similar cryopreservation services with comparable consumer pricing tiers and DTC marketing approach.
Others
- Canadian Blood Services (OneMatch): Canadian public cord blood bank and stem cell registry that competes indirectly with Insception by offering free donation-based banking as an altruistic alternative to private family banking.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks6 records
Key highlights7 records
Customer concentration
Insception Biosciences social profiles
Digital presenceInsception Biosciences compliance and trust
Trust signalCompliance4 records
Insception Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Insception Biosciences leadership team
Management profileNumber of profiles
Profiles5 records
Insception Biosciences funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Insception Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Insception Biosciences
What does Insception Biosciences do?
Insception Lifebank provides family cord blood and cord tissue banking services, collecting, processing, and cryogenically storing newborn stem cells at CooperSurgical's 80,000-square-foot facility in Tucson, Arizona. Cord blood (hematopoietic stem cells) and cord tissue (mesenchymal stem cells) are preserved for potential future use in treating 80+ diseases. The company also offers the Newborn Possibilities Program providing free processing and storage to families with qualifying medical needs.
Is Insception Biosciences a public or private company?
Insception Biosciences is a private company. It is classified as corporate owned and is currently operating.
When was Insception Biosciences founded?
Insception Biosciences was founded in 1996. It employs 51 to 100 people.
Where is Insception Biosciences based?
Insception Biosciences is headquartered in Mississauga, Canada, in the North America region.
How does Insception Biosciences make money?
Four revenue lines are on record. Cord Blood Banking Services are the primary driver. The others are cord Tissue Banking Services, prepaid Storage Plans and referral Program Revenue.
Who are Insception Biosciences's main competitors?
Direct peers on record are Cells for Life, Healthcord Cryogenics, ViaCord, Cord Blood Registry (CBR), Cryo-Cell International, StemCyte, LifebankUSA, AlphaCord and FamilyCord. Canadian Blood Services (OneMatch) is listed as an others.
Does Insception Biosciences have an API?
No public API is recorded for Insception Biosciences.
What industry is Insception Biosciences in?
Insception Biosciences's product category is Cord Blood and Tissue Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 8090.